3. dosis mims

21
Handbook of Clinical Drug Data 10th Edition 2002. DOSIS MIMS AMOKSISILIN Durasi: Dosis:  Adult  250500 !g " hrl#. $a!o%illin& !i!s' Severe renal impairment  Dos( should b( r(duc(d. Peritoneal dialysis patient  Ma%: 500 !g dail#. Gonococcal urethritis ) g as a singl( dos( $no*a%& !i!s' +(las : antibiotik golongan ,(nisilin. Adult Dosage. PO 250-500 !g " hr or 500"/5 !g bid& to a !a%i!u! of .5 gda#. PO for endocarditis prophylaxi s 2 g 1 hr b(for( d(ntal or u,,(r aira# ,roc(dur(s. Dosage or!s. "ap 250& 500 !g3 Susp 25& 50 !g!43 #a$ 500& "/5 !g. ALLOP%&INOL Durasi: Dosis :  Adult  Initiall# 100)00 !g dail#. Maint(nanc(: 20000 !g dail#. Ma%: 600 !g dail# $alluric& !i!s'. Adult  100 !g dail#. Incr(as( at kl# int(r*als b# 100 !g until nor!al s(ru! uric acid l(*(l is attain(d. Ma%: "00 !gda# $,uric(!ia& !i!s'. +(las :H#,(ruric(!ia 7 8out 9r(,arations  (longs to th( class of ,r(,ara tions inhibiting uric acid ,roduction. ;s(d in th( tr(at!(nt of gout. AMINOILIN Durasi: Dosis:  Adult  250500 !gda#$a!ino,h#llin indofar!a& !i!s'. Adult  <al 1 tab 2 %hari . Maks: 2 tab 2 %hari . Pencegahan spas!e $ron'ial  12 tab !(n=(lang tidur $,h#llocontin&!i!s'. +(las :<ntiasth!atic 7 CO9D 9r(,arations (longs to th( class of %anthin(s. ;s(d in th( s#st(!ic tr(at!(nt of obstructi*( aira# dis(as(s.

Upload: yulia-putri-carliana

Post on 13-Apr-2018

238 views

Category:

Documents


1 download

TRANSCRIPT

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 1/21

Handbook of 

Clinical Drug Data 10thEdition 2002.

DOSIS MIMS

AMOKSISILIN• Durasi:

• Dosis : Adult  250500 !g " hrl#. $a!o%illin& !i!s'Severe renal

impairment  Dos( should b( r(duc(d. Peritoneal dialysis patient  Ma%:500 !g dail#. Gonococcal urethritis ) g as a singl( dos( $no*a%& !i!s'• +(las : antibiotik golongan ,(nisilin.

• Adult Dosage. PO 250-500 !g " hr or 500"/5 !g bid& to a !a%i!u!

of .5 gda#. PO for endocarditis prophylaxis 2 g 1 hr b(for( d(ntal or

u,,(r aira# ,roc(dur(s.• Dosage or!s. "ap 250& 500 !g3 Susp 25& 50 !g!43 #a$ 500& "/5

!g.

ALLOP%&INOL• Durasi:

• Dosis : Adult  Initiall# 100)00 !g dail#. Maint(nanc(: 20000 !g dail#.

Ma%: 600 !g dail# $alluric& !i!s'. Adult  100 !g dail#. Incr(as( at kl#

int(r*als b# 100 !g until nor!al s(ru! uric acid l(*(l is attain(d. Ma%:

"00 !gda# $,uric(!ia& !i!s'.• +(las :H#,(ruric(!ia 7 8out 9r(,arations  (longs to th( class of

,r(,arations inhibiting uric acid ,roduction. ;s(d in th( tr(at!(nt of gout.

AMINOILIN• Durasi:

• Dosis : Adult  250500 !gda#$a!ino,h#llin indofar!a& !i!s'. Adult  <al

1 tab 2 %hari. Maks: 2 tab 2 %hari. Pencegahan spas!e $ron'ial 12

tab !(n=(lang tidur $,h#llocontin&!i!s'.• +(las :<ntiasth!atic 7 CO9D 9r(,arations  (longs to th( class of

%anthin(s. ;s(d in th( s#st(!ic tr(at!(nt of obstructi*( aira# dis(as(s.

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 2/21

AMI#&IP#ILIN• Durasi:

• Dosis :Out-patient  Initiall# 2 tab dail#. In-patient  Initiall# 1 tab ) ti!(s

dail#& !a# b( incr(as( u, to " tabs dail#. Ma%: 12 tab dail#. Maint(nanc(:

1 tab dail#. $trilin&!i!s'Eld(rl# :d(,r(ssion: oral: initial: 1025!g at b(dti!(& dos( should b(

incr(as(d in 1025 !g incr(a!(nts (*(r# ((k if tol(rat(d3 dos( rang( :

25150!gda# $DI>&20 ?H EDI?IO@'.• +(las :<ntid(,r(ssants& (longs to th( class of nons(l(cti*( !onoa!in(

r(u,tak( inhibitors. ;s(d in th( !anag(!(nt of d(,r(ssion.

AMLODIPIN(• Durasi :

• Dosis : 5 !g onc( dail#. Ma%: 10 !gda#. Patients w/ hepatic

insufciency, elderly  Initiall# 2.5 !g.

• +(las : (longs to th( class of dih#dro,#ridin( d(ri*ati*( s(l(cti*(

calciu!chann(l block(rs ith !ainl# *ascular (A(cts. ;s(d in th(

tr(at!(nt of cardio*ascular dis(as(s. $sanb(&!i!s'

AMPI"ILLIN• Durasi :

• Dosis : Oral  Adult & childn ≥2 !" 250500 !g hrl#& #2 !" 50100

!gkg bod# t dail# in di*id(d dos(s hrl#. Inj  Adult & childn $2!" 250500 !g ti!(s dail# IMIB& #2 !" 100200 !gkg bod# tda#

IMIB in (uall# di*id(d dos(s hrl#& in%ant $ days /5 !gkgda# IMIB

in di*id(d dos(s " hrl#& # days 50 !gkgda# IMIB in di*id(d dos(s 12

hrl#. Meningitis  Adult & childn $2 !" "1 g IB dail# ) hrl#& #2

!" 150250 !gkgda# IB in di*id(d dos(s hrl#& in%ant $ days 150

200 !gkgda# IB in di*id(d dos(s " hrl#& # days 100 !gkgda# IB in

di*id(d dos(s 12 hrl#.

• +(las : a!,icillin 3 (longs to th( class of ,(nicillins ith (%t(nd(d

s,(ctru!. ;s(d in th( s#st(!ic tr(at!(nt of inf(ctions.$sanb(&!i!s'.

AN#ASID• Durasi:

• Dosis : )% $12'tabl(t

• +(las :

• Ad!inistration and Adult Dosage. PO for sy!pto!atic relief of

indigestion) nonulcer dyspepsia) epigastric pain in P%D) or

heart$urn in gastroesophageal re*ux disease +G(&D, 10-)0 !4 ,rn or 1 and ) hr aft(r !(als and hs.1&2 PO for treat!ent of P%D 100-10

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 3/21

!E of acidn(utraliing ca,acit# ,(r dos(& gi*(n 1 and ) hr aft(r !(als

and hs for -" ((ks or until h(aling is co!,l(t(. <dditional dos(s !a# b(

tak(n if (,igastric ,ain ,(rsists. ?h(r( is (*id(nc( that lo(r dosag(s can

h(al ,(,tic ulc(rs.1&2 PO or NG for pre-ention or treat!ent of upper

GI $leeding in critically ill patients titrat( to !aintain intragastric ,H

.0.) PO for phosphate $inding in renal failure $alu!inu!h#dro%id(' 1.6-." g tid or id or $calciu! carbonat(' "-12 gda#3 titrat(

dosag( bas(d on s(ru! ,hos,hat(.

AN#ASID S&%P• Durasi:

• Dosis : 12 s(ndok sus,(nsi

• +(las :

ASIKLO/I&• Durasi:

• Dosis : Adult #reat!ent of herpes si!plex infections 200 !g 5 ti!(s

dail# hrl#.. Suppression of herpes si!plex infections 200 !g

ti!(s dail# hrl#. #reat!ent of herpes 0oster infections "00 !g 5

ti!(s dail# hrl# for / da#s. $clino*ir tabl(t& !i!s'• +(las :<nti*irals& (longs to th( class of nucl(osid(s and nucl(otid(s

(%cluding r(*(rs( transcri,tas( inhibitors. ;s(d in th( s#st(!ic tr(at!(ntof *iral inf(ctions $clino*ir tabl(t& !i!s'.

ASIKLO/I& "&(AM• Durasi: 5H<I.

• Dosis : <,,l# 5 ti!(s dail# hrl# o night dos(. Duration of tr(a!(nt: 5

da#s& !a# b( continu(d until 10 da#s $<CI>< CEM& MIMS'• +(las : ?o,ical <nti*irals& aciclo*ir 3 (longs to th( class of to,ical

anti*irals us(d in th( tr(at!(nt of d(r!atological dis(as(s $<CI>< CEM&MIMS'.

"AL"I%M LA"#A#(• Durasi :

• Dosis : 1 ca, dail#

• +(las : calciu! lactat( 3 (longs to th( class of calciu!containing

,r(,arations. ;s(d as di(tar# su,,l(!(nts. $graha far!a&!i!s'

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 4/21

"AP#OP&IL• Durasi:

• Dosis : 1#N Adult  Initiall# 12.525 !g 2) ti!(s dail#. Ma# incr(as( to 50

!g 2) ti!(s dail# aft(r 2 k if 9 is not lo(r(d suFci(ntl#. Ma%: 150 !g

dail#.Se-ere 1#N

 Ma%: 50 !g dail#.1eart failure

 12.525 !g ) ti!(sdail# $far!ot(n&!i!s'.• +(las : <CE InhibitorsDir(ct (nin Inhibitors& (longs to th( class of <CE

inhibitors. ;s(d in th( tr(at!(nt of cardio*ascular dis(as(

$far!ot(n&!i!s'.• Adult Dosage. PO for hypertension 12.5-25 !g bid-tid initiall#&

incr(asing aft(r 1-2 ((ks to 50 !g bid-tid& to a !a%i!u! of 50 !gda#.

PO for "1 .25-25 !g tid initiall#& incr(asing o*(r s(*(ral da#s bas(d

on th( ,ati(ntGs tol(ranc( to a dosag( of 50 !g tid. D(la# furth(r dosag(

incr(as(s& if ,ossibl(& for at l(ast 2 ((ks to (*aluat( r(s,ons(. Most

,ati(nts r(s,ond to 50-100 !g tid. or hypertension or "1 us( initial

dosag(s of .25-12.5 !g bid-tid and incr(as( slol# in ,ati(nts on diur(tic

th(ra,#& ith sodiu! r(striction& or ith r(nal i!,air!(nt. PO for left

-entricular dysfunction post2MI .25 !g onc( at ) or !or( da#s ,ost

MI and th(n 12.5 !g tid3 incr(as( to 25 !g tid o*(r s(*(ral da#s to a

targ(t of 50 !g tid o*(r s(*(ral ((ks as tol(rat(d. PO for dia$etic

nephropathy 25 !g tid.

"IP&OLOKSASIN• Durasi:

• Dosis :Tab%#I Mild!od(rat(: 250 !g 2 ti!(s dail#. S(*(r(: 500 !g 2

ti!(s dail#. &esp tract) $one 3 4oint) s'in 3 soft tissue infections 

Mild!od(rat(: 500 !g 2 ti!(s dail#. S(*(r(: /50 !g 2 ti!(s dail#. Acute

gonorrhoea 250 !g singl( dos(. Inj Adult %nco!plicated 'idney

infections 3 upper 3 lo5er %#I 100 !g tic( dail#. Other infections 

200 !g tic( dail#. Acute gonorrhoea 3 unco!plicated acute

cystitis in 5o!en 100 !g as a singl( dos( $r(nator&!i!s'.• +(las : ;I@O4O@& (longs to th( class of uorouinolon(s. ;s(d in th(

s#st(!ic tr(at!(nt of inf(ctions.

"#M• Durasi: hr.

• Dosis : Adult  1 ca,l(t. ?o b( tak(n ) ti!(s dail# $or,h(n&!i!s'.

hour all(rg# tabl(t 1 tabl(t $ !g' (*(r# to hours u, to a !a%i!u!

of tabl(ts in 2 hours3 "hour all(rg# tabl(t 1 tabl(t $" !g' (*(r# " to

12 hours u, to ) tabl(ts in 2 hours3 12hour tabl(t 1 tabl(t $12 !g'

(*(r# 12 hours u, to 2 tabl(ts in 2 hours .

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 5/21

$9roduct Infor!ation: Chlor?ri!(ton$'& chlor,h(nira!in(& Sch(ring9lough H(althcar( 9roducts&

+(nilorth& @J& 1666. Chlor?ri!(ton$'& chlor,h(nira!in(& Sch(ring9lough H(althcar( 9roducts&

+(nilorth& @J& 1666.'

b' >or th( ,r(*(ntion of all(rgic rhinitis s#!,to!s& ad!inist(r

chlor,h(nira!in( !g $s#ru, or ,lain& uncoat(d tabl(t' and incr(as( )ti!(s dail# (*(r# ) da#s as tol(rat(d until r(aching " !g ) ti!(s dail#.

Start b(for( th( all(rg# s(ason $for rag((d <ugust 1st' and continu(

until inhalant all(rg(n is gon( $Krst frost in rag((d ar(as'. Most ,ati(nts

d(*(lo, tol(ranc( to th( s(dati*( (A(ct if dos( is start(d lo and

incr(as(d in s!all incr(!(nts $onl# h(n ,r(*ious lo(r dos( is tol(rat(d'

$Long 4& H(nd(l(s 4& 7 L(inb(rg(r M: 9lac(bocontroll(d (*aluation of h#dro%#in( and

chlor,h(nira!in( for s(asonal all(rgic rhinitis. 9r(s(nt(d at <!(rican <cad(!# of <ll(rg#& $M<'

16/6& $abstract 2)'. J <ll(rg# Clin I!!unol 16/63 )$)':20).'

•+(las :<ntihista!in(s 7 <ntiall(rgics& (longs to th( class of substitut(dalk#la!in(s us(d as s#st(!ic antihista!in(s.

"O#&IMO6A7OL(• Durasi :

• Dosis : s(hari 2%2 tab& s(la!a 101 hari3shig(llosis: s(la!a 5 hari3 inf(ksi

b(rat dosis da,at dinaikkan 1&5% dala! dosis t(rbagi )3 gangguan fungsi

gin=al d(ngan klir(nsi kr(atinin 15)0!l!nt:12 dosis lai!3klir(nsi

kr(atinin &15!l!nt3 ,(!b(rian tidak dian=urkan•

+(las :• PO for %#I 10 !g of ?M9 and "00 !g of SM 12 hr for 10-1 da#s. PO

for prophylaxis of recurrent %#I 0 !g ?M9 and 200 of SM at

b(dti!( ) ti!(s a ((k. PO for shigellosis 10 !g of ?M9 and "00 of

SM 12 hr for 5 da#s. I/ for se-ere Gra!2negati-e infections or

shigellosis "-10 !gkgda# of ?M9 and 0-50 !gkgda# of SM& in 2-

(uall# di*id(d dos(s& -12 hr for 5 da#s for shig(llosis and u, to 1

da#s for s(*(r( ;?I. PO or I/ for P' carinii pneu!onia +P"P, 12.5-20

!gkgda# of ?M9 and 2.5-100 !gkgda# of SM& in 2- (uall# di*id(d

dos(s& for u, to 21 da#s. PO for P"P infection prophylaxis 10 !g of

 ?M9 and "00 !g of SM onc( dail#3 int(r!itt(nt dosag( $(g& ) ti!(s a((k' is also us(d. In ,ati(nts ith HIB inf(ction& th( drug is indicat(d if

th(r( as a ,r(*ious (,isod( of 9C9 or CD counts ar( N200 c(lls4.

D(KS#&OM(#1&OPAN 18&• Durasi: Oral: ;, to hr.

• Dosis : 10-)0 !g -" hr& to a !a%i!u! of 120 !gda#3 S& 0 !g 12

hr.

• +(las :Cough 7 Cold 9r(,arations & (longs to th( class of o,iu! alkaloidsand d(ri*ati*(s. ;s(d as cough su,,r(ssant.

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 6/21

D(6AM(#1ASON(• Durasi: /2 hr.

• Dosis :Tab 1 tab dail# in di*id(d dos( $corsona& !i!s'. Tab Adult  0.56!g in di*id(d dos(s. Intensi-e therapy or e!ergency 2 !g " ti!(s

dail#. Ma% dail# dos(: 50 !g. Shoc' condition 1 !gkg bod# t

$cortid(%&!i!s'.• +(las :Corticost(roid Hor!on(s& (longs to th( class of glucocorticoids.

;s(d in s#st(!ic corticost(roid ,r(,arations.•  ?otal dail# dosag( is *ariabl( d(,(nding on th( clinical disord(r and

,ati(nt r(s,ons(. @ot r(co!!(nd(d for alt(rnat(da# ad!inistration

b(caus( of ,rolong(d duration of acti*it#. PO) IM) or I/ for acute) self2

li!ited allergic disorders or exacer$ation of chronic allergic

disorders -" !g on th( Krst da# in on( dos(& th(n ta,(r o*(r 5 da#s3gi*( ta,(ring dosag( in 2 di*id(d dos(s for ) da#s& onc( dail# for 2 da#s&

th(n discontinu(. I/ for cere$ral ede!a 10 !g $as th( sodiu!

,hos,hat(' initiall#& follo(d b# !g IM or IB hr for s(*(ral da#s until

!a%i!al r(s,ons( occurs3 th(n d(cr(as( th( dosag( o*(r 5-/ da#s and

discontinu(.

DIA7(PAM• Durasi:

• Dosis :Oral 25 !g ) ti!(s dail# $st(solid& !i!s'. Anxiety 3 ad4unct in

!uscle spas!s 210 !g 2 ti!(s dail# d(,(nding on th( s(*(rit#.

Alcohol 59dra5al 10 !g ) ti!(s dail# in th( 1st 2 hr& th(n 5 !g )

ti!(s dail#. (lderly & de)ilitated patients Initial dos(: 12.5 !g )

ti!(s dail# $*aldi!(%&!i!s'.• +(las :<n%iol#tics& (longs to th( class of b(nodia(,in( d(ri*ati*(s

an%iol#tics. ;s(d in th( !anag(!(nt of an%i(t#& agitation or t(nsion.

DI"1LO(NA" PO#ASSI%M• Durasi :

• Dosis :<dult 100150 !g dail#. Mild(r cas(s 7 childn 1 #r /5100 !g

dail#. Dail# dos( should b( gi*(n in 2) di*id(d dos(s.

$<MOPI@DO><M<&MIMS'

• +(las : (longs to th( class of ac(tic acid d(ri*ati*(s and r(lat(d

substanc(s of nonst(roidal antiina!!ator# and antirh(u!atic ,roducts.

$,haros&!i!s'

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 7/21

DI"LO(NA" SODI%M• Durasi :

• Dosis :?ab <dult 50 !g 2) ti!(s dail#. Mild(r cas(s: /5100 !g dail#. S

tab <dult Initiall# 100150 !g dail#. In !ild(r cas(s& 1 tab is usuall#

suFci(nt. (tard tab 100 !g dail# or 2 tab of Boltar(n S /5. IMIBinfusion <dult 12 a!, $in s(*(r( cas(s' dail# for Q2 da#s. Su,, <dult ?o

50 !g su,, or on( 100 !g su,, at night. Mor( s(*(r( cas(s: Co!bin(

25 or 50 !g tab. Ma%: 150 !g dail#.• +(las : 8

((D&IN• Durasi: ) hr $oral'.

• Dosis :

• +(las :

(&GO#AMIN(• Durasi:

• Dosis : ?h( usual oral dos( of (rgota!in( is 1 to 2 !illigra!s initiall# th(n

1 to 2 !illigra!s (*(r# )0 to 0 !inut(s. ?h( !a%i!u! r(co!!(nd(d

dos( is !illigra!s2 hours and 10 !illigra!s((k R13 $os(ll (t al&

16/)'

• +(las :<nti!igrain( 9r(,arations• Ad!inistration and Adult Dosage. PO for !igraine 2 !g initiall#&

th(n 1 !g (ach 1TU hr ,rn& to a !a%i!u! of !gda# or 10 !g((k3 P&

2 !g initiall#& !a# r(,(at in 1 hr ,rn& to a !a%i!u! of !gattack or 10

!g((k3 SL 2 !g initiall#& th(n 2 !g )0 !in as n((d(d& to a !a%i!u!

of !gda# or 10 !g((k./ ?itrat( th( dosag( during s(*(ral attacks

graduall#& th(n ad!inist(r th( !ini!u! (A(cti*( dosag( ith subs(u(nt

attacks. 9ati(nts ho routin(l# r(uir( o*(r 2 !gh(adach( can b( gi*(n

th( total (A(cti*( dosag( at th( ons(t of th( h(adach(.

GL"(&L G%AI"OLA#( +GG,• Durasi :

• Dosis : 2 tab tia, =a! !aksi!u! 2 tab ,(rhari $sa!,harindi&ISO

BO4&986'• +(las :

• Ad!inistration and Adult Dosage. PO as an expectorant 100-00

!g  hr3 S& 00-1200 !g 12 hr& to a !a%i!u! of 2. gda#."

Geriatric Dosage. Sa!( as adult dosag(.

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 8/21

GLI8(NKLAMID(• Durasi: Q2 hr.

• Dosis :Initiall# 2.55 !g dail#& should b( ad=ust(d in st(,is( dos( of 2.5

!g at about 1 k int(r*al. Ma% dosag(: 10 !gda# $,adonil& !i!s'.

Initiall# 5 !g dail#. Should b( ad=ust(d in st(, of 2.5 !g at int(r*als ofabout 1 k. Ma%: 15 !gda# $condiab(t&!i!s'.Eld(rl# initial : 1.252.5!gda#& incr(as( b# 1.252.5!gda# (*(r# 1)

((ks$DIH 20th (dition'• +(las :<ntidiab(tic <g(nts& (longs to th( class of sulfona!id(s& ur(a

d(ri*ati*(s. ;s(d in th( tr(at!(nt of diab(t(s.• 1.25-20 !g in 1-2 di*id(d dos(s

1ID&OKLO&#IA7ID +1"#,• Durasi: 12 hr.

• Dosis :hipertensi : initial, 25 mg ORALLY once daily; may increase to 50 mg

ORALLY daily in single or 2 divided doses. Edema 25 to 100 !g O<44V dail#

in singl( or di*id(d dos( (9roduct Infor!ation: h#drochlorothiaid( oral

tabl(ts& h#drochlorothiaid( oral tabl(ts. M#lan 9har!ac(uticals Inc $,(r

>D<'& Morganton& LB& 2011'.• +(las : diur(tik& (longs to th( class of loc(iling thiaid( diur(tics.

1D&O"O&#ISON(• Durasi:

• Dosis:

• +(las: h#drocortison( 3 (longs to th( class of (ak $grou, I'

corticost(roids. ;s(d in th( tr(at!(nt of d(r!atological dis(as(s. $indo

far!a&!i!s'

I8%P&O(N• Durasi: hr $oral'. $MIMS'

• Dosis : <dult  00 !g ) ti!(s dail#. Analgesia 20000 !g ) ti!(sdail#. $ar(f(n&!i!s'.

• +(las :@onst(roidal <ntiIna!!ator# Drugs $@S<IDs' Oth(r

Cardio*ascular Drugs $MIMS'

ISDN• Durasi: 2 hrs $sublingual'3 hr $oral as con*(ntional tab'.

• Dosis :Angina pectoris 1 tab sublinguall#. Pre-ention of anginal

attac's ) tab dail# $isorbid&!i!s'.5-mg SL tab 12 tab 2) hrl# as

r(uir(d. 10-mg tab Adult  1 tab ti!(s dail# or 1 tab b(for( sl((,ing for,ro,h#la%is $farsorbid&!i!!s'. Adult Cedocard 5 tabAngina acute attac' 

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 9/21

1 tab. 9ro,h#la%is: 12 tab ) ti!(s dail#. Pre-ention of nocturnal

attac's 12 tab b(for( sl((,. Cedocard 10 tab 1) tab ti!(s dail#.

Cedocard 20 tabPre-ention of expected attac' or of nocturnal

angina 1 tab. 8(n(ral dos(: )010 !gda#& tak(n ) ti!(s dail#. "1 

Initiall# W tab. EA(cti*( dos(: 010 !g dail#& in s(*(r( cas(s u, to 20

!g dail#. Cedocard IV in!sion 210 !ghr. Cedocard "etard tab 1 tab 2ti!(s dail#.$c(docard&!i!s'.

• +(las :<nti<nginal Drugs& (longs to th( class of organic nitrat(

*asodilators. ;s(d in th( tr(at!(nt of cardiac dis(as(.

K(#OKONA7OL(• Durasi:

• Dosis : Adult  1 tab onc( dail#. S(*(r( inf(ction: 2 tab dail#

$for!#co&!i!s'. Adult  1 tab dail#. *hildn 50100 !g dail#. /ag

candidosis 2 tab onc( dail# for 5 da#s $fun(t&!i!s'. Adult 1 tab dail#3!a# b( incr(as(d to 2 tab dail# if r(s,ons( is insuFci(nt. /ag

candidiasis 2 tab onc( dail# for 5 da#s$!#cod(r!'.• +(las :<ntifungals& (longs to th( class of i!idaol( d(ri*ati*(s. ;s(d in

th( s#st(!ic tr(at!(nt of !#cotic inf(ctions.

KLO&AM(NIKOL•

Durasi: ?#,hoid: "10 da#s3 !(ningitis: /10 da#s3 brain absc(ss: ;, to k.• Dosis :Ca# Adult  12 ca, ) ti!(s dail#. S$r  Adult  ) ts, ) ti!(s dail#.

*hildn +- yr  2 ts, ) ti!(s dail#& - yr  1 ts, ) ti!(s dail#. In%ant  

W ts, ) ti!(s dail#. $colsanc(tin(& !i!s'.• +(las :Chlora!,h(nicols& (longs to th( class of a!,h(nicols. ;s(d in th(

s#st(!ic tr(at!(nt of inf(ctions.

KLO&AM(NIKOL #(#(S MA#A• Durasi:

• Dosis : %$e dro#s Instill 2 dro,s ) ti!(s dail#. %$e oint  <,,l# a suFci(nt

a!ount ) ti!(s dail# $r(co&!i!s'.• +(las : E#( <ntiInf(cti*(s 7 <ntis(,tics& (longs to th( class of

antibiotics. ;s(d in th( tr(at!(nt of (#( inf(ctions.

KLO&AM(NIKOL SAL(P• Durasi:

• Dosis : <,,l# ) ti!(s dail#.

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 10/21

• +(las : ?o,ical <ntibiotics& (longs to th( class of oth(r to,ical antibiotics

us(d in th( tr(at!(nt of d(r!atological dis(as(s.

LO&A#ADIN(• Durasi:2 hr.

• Dosis : Adult & childn $2 yr  1 tab or 2 ts, onc( dail#.$4ESID<S&MIMS'.

• +(las :<ntihista!in(s 7 <ntiall(rgics& (longs to th( class of oth(r

antihista!in(s for s#st(!ic us(.

L%MINAL9P1(NO8A&8I#AL• Durasi :

• Dosis :

• +(las :,h(nobarbital 3 (longs to th( class of barbiturat(s and d(ri*ati*(s

anti(,il(,tics.

M(#O&MIN• Durasi:

• Dosis :1 tab 2) ti!(s dail# $diafac& !i!s'. 500 mg tab 1 tab ) ti!(s

dail#. &50 mg tab 1 tab tic( dail#. Ma%: ) gda#. Co!bination th(ra,#: 1

500-mg tab or W1 &50-mg tab& !a# b( incr(as(d a kl# int(r*als

$gluco,hag(& !i!s'.• +(las :<ntidiab(tic <g(nts & (longs to th( class of biguanid(s. ;s(d in

th( tr(at!(nt of diab(t(s.

M(#&ONIDA7OL(• Durasi :

• Dosis :?ab ?richo!oniasis 250 !g ) ti!(sdail# for /10 da#s. If r(uir(d&

2nd dos( aft(r k. Childn 10 #r 200250 !g ) ti!(sdail# for / da#s&

510 #r )/5 !gdail#& )5 #r 250 !gdail#& N) #r 150 !gdail#. Dos(s to b(

tak(n for / da#s. <!o(biasis <dult /50 !g ) ti!(sdail# for /10 da#s or 2

g onc( dail# for 2 da#s. Childn )550 !gkgda# in ) di*id(d dos(s for 10

da#s. <na(robic inf(ctions 9r(*(ntion: <dult 1 g as a singl( dos( ,r(o,&th(n 250500 !g ) ti!(sda# or as a singl( dos(. Childn )0 !gkg as a

singl( dos( 2 hr ,r(o,& th(n !gkg ) ti!(sdail# for 5 da#s. ?r(at!(nt:

<dult 500 !g ) ti!(sdail# for / da#s. Childn /.5 !gkg ) ti!(sdail#.

Infusion at(: 5 !4!in. <dult ?r(at!(nt 500 !g IB infusion. Childn /.5

!gkg bod# t " hrl#. <na(robic inf(ctions 9r(*(ntion: <dult 500 !g IB

infusion follo(d b# 500 !g oral ad!inistration. Childn /.5 !gkg bod# t

" hrl#. Su,, ?r(at!(nt of id(ntiK(d ana(robic bact(rial inf(ction <dult 1

su,, " hrl#. Childn /.5 !gkg bod# t " hrl#. 9r(*(ntion of ,osto,

inf(ction du( to ana(robic bact(ria <dult 1 su,, 2 hr ,r(o, th(n " hrl#

,osto,. Childn W or X of 500!g su,, " hrl#. $S<@E&MIMS'

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 11/21

 ?richo!oniasis <dult 2 g dail# in a singl( dos( or 500 !g tic( dail# for /

da#s. ?o ,r(*(nt r(inf(ction& th( ,artn(r should b( tr(at(d si!ultan(ousl#

th( sa!( dos(. Childn 15 !gkg bod# tda# in ) di*id(d dos(s for /

10 da#s. Int(stinal a!o(biasis <dult /50 !g ) ti!(s dail# for 510 da#s.

H(,atic a!o(biasis 500/50 !g ) ti!(s dail# for 510 da#s. Childn )550

!gkg bod# tda# in ) ti!(s dail# for 10 da#s. 8iardiasis <dult 2 g onc(dail# for ) da#s or 250500 !g ) ti!(s dail# for 5/ da#s. Childn 15 !gkg

bod# t in ) di*id(d dos(s for 5/ da#s. <na(rob( inf(ction <dult /.5

!gkg bod# t hrl#& $Ma%: g dail#' for /10 da#s. $9H<OS&MIMS'

• +(las : 8$S<@E&MIMS'

M((N(MI" A"ID•

Durasi :• Dosis :<dult Initiall# 500 !g th(n 250 !g hrl#.

• +(las : 8

MOLAGI#• Durasi :

• Dosis: <dult 7 childn 12 #r 2 ca,l(t aft(r (ach subs(u(nt bo(l

!o*(!(nt. Ma%: 12 ca,l(tda#.• +(las : atta,ulgit(& co!binations 3 (longs to th( class of oth(r int(stinal

adsorb(nts.$antidiarrh(alR!i!s class' $ar!o%indofar!a&!i!s'

NI(DIPIN(• Durasi:

• Dosis :510 !g ) ti!(s dail# $calcianta&!i!s'. Sta$le) -ariant 3

unsta$le angina pectoris) cardiac infarction Initiall# 1 tab ) ti!(s

dail#. Ma# incr(as( u, to 612 tab in di*id(d dos(s dail# in ,ati(nts

angina. 1#N) &aynaud;s syndro!e Ma# incr(as( u, to 2 tab ) ti!(s

dail# $nif(din&!i!s'. "hronic heart disease Adult  510 !g ) ti!(s dail#.Dos( !a# b( graduall# incr(as(d to 20 !g ) ti!(s dail#. "oronary

spas!s +unsta$le 3 Prin0!etal;s angina) angina at rest, 20 !g

ti!(s dail#. 1#N 10 !g ) ti!(s dail#. Ma%: 20 !g ) ti!(s dail# $far!alat'.• +(las :Calciu! <ntagonists& (longs to th( class of dih#dro,#ridin(

d(ri*ati*( s(l(cti*( calciu!chann(l block(rs ith !ainl# *ascular (A(cts.

;s(d in th( tr(at!(nt of cardio*ascular dis(as(s.

PAPA/(&IN

• Durasi:• Dosis :

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 12/21

• +(las :

PA&A"(#AMOL• Durasi : hr $analg(sia'. IB: Y hr $anti,#r(tic'.

• Dosis : Tab Adult . ?o b( tak(n ) ti!(s dail#. Ma% dail# dos(:  g. Dos(s

should b( gi*(n at l(ast hr int(r*al. $far!adol& !i!s'• +(las : analg(sik $non o,iodida' 7 anti,ir(tik.

• Ad!inistration and Adult Dosage. PO for pain or fe-er $nonS'

)25-1000 !g - hr& to a !a%i!u! of gda#3 $S ?ab' 1)00 !g " hr.

P& for pain or fe-er 50 !g - hr& to a !a%i!u! of gda#.• Ad!inistration and Adult Dosage.

• PO for pain or fe-er $nonS' )25-1000 !g - hr& to a !a%i!u! of

gda#3 $S ?ab' 1)00 !g " hr. P& for pain or fe-er 50 !g - hr& toa !a%i!u! of gda#.

PI&O6I"AM• Durasi:

• Dosis :&A) OA +arthrosis) generati-e 4oint disease) an'ylosing

spondylitis, Initiall# 20 !g dail# as a singl( dos(. Acute gout Initiall# 0

!g dail# as a singl( dos(& follo(d b# 0 !g dail# on th( n(%t da#s in

singl( or di*id(d dos(s. Acute !usculos'eletal disorders Initiall# 0

!g dail# for th( 1st 2 da#s in singl( or di*id(d dos(s. >or th( r(!aind(r of /1 da#s tr(at!(nt ,(riod& r(duc( dos( to 20 !g dail# $(ro%i&!i!s'.

 Adult  20 !g dail# as a singl( dos( $ca!,ain'.• +(las :@onst(roidal <ntiIna!!ator# Drugs $@S<IDs'& (longs to th(

class of nonst(roidal antiina!!ator# and antirh(u!atic ,roducts&

o%ica!s.

P1(N#1OIN• Durasi :

• Dosis :Oral <dult Initiall# 100 !g ) ti!(s dail#. Childn 5 !gkg bod#

tda# in 2 or ) di*id(d dos(s. Ma%: )00 !g dail#. In= Ma%: 50 !g!in IB.

Status (,il(,ticus 1015 !gkg bod# t slo IB $a,,ro% 20 !in in a /0 kg

,ati(nt'& follo(d b# a !aint(nanc( dos( of 100 !g orall# or IB (*(r# "

hrl#. @(urosurg(r# 100200 !g IM hrl# 7 ,osto,. Cardiac arrh#th!ia

).55 !gkg bod# t& r(,(at(d onc( if n(c(ssar#. ?otal dail# dosag(: /00

1000 !g.• +(las : ,h(n#toin 3 (longs to th( class of h#dantoin d(ri*ati*(s

anti(,il(,tics. $9K(r&!i!s'

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 13/21

P&(DNISON(• Durasi:

• Dosis : s(hari 1 tab. !aks s(hari 2% tab $b(rliko !ulia far!a& ISO BO4

&98 26/'• +(las :Corticost(roid Hor!on(s& (longs to th( class of glucocorticoids.

;s(d in s#st(!ic corticost(roid ,r(,arations.

&ANI#IDIN(• Durasi:

• Dosis :Acti-e duodenal ulcer 150 !g 2 ti!(s dail# or )00 !g onc( dail#

at b(dti!( for " k. Acti-e $enign gastric ulcer 150 !g 2 ti!(s dail#

for " k. &e*ux oesophagitis 150 !g 2 ti!(s dail# for Q" k.

Pre-ention of peptic ulcer relapse 150 !g at b(dti!( for 12 !th.Pathological hypersecretory conditions Initiall# 150 !g ) ti!(s dail#

7 !a# incr(as( to Q gda# in di*id(d dos(s. Impaired renal %unction,

*r*l . m/min 150 !g 2 hrl# $ranin&!i!s'. tab'Ca#let Peptic ulcer 

150 !g 2 ti!(s dail#. 7ollinger2(llison syndro!e 150 !g 2 ti!(s dail#.

Se-ere cases ;, to gdail#. (m#I) 50 !g2 !4 " hrl#. IV intermittent

bol!s 50 !g $2 !4' " hrl# $acran& !i!s'.• +(las :<ntacids& <ntir(u% <g(nts 7 <ntiulc(rants& (longs to th( class of

H2r(c(,tor antagonists. ;s(d in th( tr(at!(nt of ,(,tic ulc(r and gastro

o(so,hag(al r(u% dis(as( $8ED'.

&(S(&PIN(• Durasi:

• Dosis :hipertensi) initial& 0.5 !gda# O<44V for 1 to 2 k3 !aint(nanc(&

0.1 to 0.25 !gda# O<44V. Psychotic) usual dos(& 0.5 !gda# O<44V3

rang( 0.1 to 1 !gda# $9roduct Infor!ation: r(s(r,in( oral tabl(ts&

r(s(r,in( oral tabl(ts. Eon 4abs&Inc& 4aur(lton& @V& 200'.• +(las :Oth(r <ntih#,(rt(nsi*(s& (longs to th( class of rauolKa alkaloids&

c(ntrall#acting antiadr(n(rgic ag(nts. ;s(d in th( tr(at!(nt of

h#,(rt(nsion.

SAL8%#AMOL• Durasi: oral: " hr3 !odiK(dr(l(as( ,r(,aration: 12 hr.

• Dosis :Tab Adult  2 !g& S$r  Adult  510 !4. <ll dos(s ar( to b( tak(n )

ti!(s dail#$ astharol&!i!s'• +(las :<ntiasth!atic 7 CO9D 9r(,arations& (longs to th( class of

adr(n(rgic inhalants& s(l(cti*( b(ta2adr(nor(c(,tor agonists. ;s(d in

th( tr(at!(nt of obstructi*( aira# dis(as(s.

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 14/21

• Ad!inistration and Adult Dosage. Inhal for asth!a $!(t(r(ddos(

inhal(r' 60-1"0 g $1-2 ,uAs' - hr ,rn and =ust b(for( (%(rcis(3

$inhalation solution' 2.5 !g b# n(buliation tid-id3 $inhalation ca,sul(' 1-

2 inhalation ca,sul(s - hr or 1 ca,sul( 15 !in b(for( (%(rcis(. Inhal

for se-ere $ronchospas! n(buli(d b# co!,r(ss(d air or o%#g(n 2.5-5

!g $0.5-1 !4 of 0.5Z in 2-) !4 @S' - hr ,rn $ 1-2 hr und(r !(dical

su,(r*ision'.• PO for asth!a 2- !g -" hr& incr(as( as tol(rat(d to a !a%i!u! of

)2 !gda#3 S& #a$ -" !g 12 hr& to a !a%i!u! of )2 !gda#.

SIM/AS#A#IN• Durasi:

•Dosis :Initiall# 5 or 10 !g onc( dail# in th( (*(ning. <d=ust dosag( at Yk int(r*als to !a% of 0 !g dail# $d(tro*(l&!i!s'. Adult  Initiall# 10

!gda#. Ma%: 0 !gda#. Mild to !oderate hypercholesterole!ia 5

!gda#. <ll dos(s to b( tak(n as a singl( dos( in th( (*(ning. <d=ust dos(

at kl# int(r*al as r(uir(d $*al(!ia&!i!s'.• +(las :D#sli,ida(!ic <g(nts& (longs to th( class of HM8 Co< r(ductas(

inhibitors. ;s(d in th( tr(at!(nt of h#,(rli,id(!ia.

S%LA"(#AMID(•

Durasi :• Dosis :

• +(las :

SODI%M 8I"A&8ONA#( <==!g• Durasi:

• Dosis : usual dos( is b(t((n 15gr. Ma%i!u! dail# dos( is 5gr

• +(las : antacids $focus,har!ac(uticals'

#(#&A""LIN(• Durasi :

• Dosis :1 ca, ti!(s dail#. 8rucellosis 500 !g ti!(s dail# for )

k. Syphilis )00 g in (uall# di*id(d dos(s for 15 da#s.• +(las : (longs to th( class of t(trac#clin(s. ;s(d in th( s#st(!ic

tr(at!(nt of inf(ctions.$<r!o%indo >ar!a&!i!s'

#&I1(KSIP1(NIDL• Durasi :

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 15/21

• Dosis : 1st da#: 1 !g. 2nd da#: 2 !g furth(r incr(as( of 2 !g dail# at )

5 da#s int(r*al& u, to 10 !g dail# in ) di*id(d dos(s. So!( ,ati(nts

!a# r(uir( total dos( of 1215 !g dail#. Druginduc(d ,arkinsonis! 515

!g dail#& ad*isabl( to initiat( th(ra,# singl( 1 !g dos(. 9ati(nt 5 #r

S!all(r dos(s r(uir(d.$,#rida!&!i!s'

Initiall# 12 !gda# th(n 2 !gda# at )5 da#s int(r*al& !a# incr(as( u, to

10 !g or 1215 !g dail# in ) di*id(d dos(s& until clinical (A(ct is

obtain(d. $hars(n&!i!s'

• +(las : trih(%#,h(nid#l 3 (longs to th( class of t(rtiar# a!in(s

anticholin(rgic ag(nts. ;s(d in th( !anag(!(nt of 9arkinson[s dis(as(.

/I#AMIN 8>•

Durasi:• Dosis :12% 1tab 50!g $?rifa&ISO BO4 & 98 55"'

• +(las :Multi*ita!ins& ,lain 3 ;s(d as di(tar# su,,l(!(nts $n#co!(d&!i!s'

/I#AMIN 8>?• Durasi:

• Dosis :

• +(las :!ulti*ita!ins and oth(r !in(rals& incl. co!binations 3 (longs to

th( class of !ulti*ita!ins ith !in(rals. ;s(d as di(tar# su,,l(!(nts$nufarindo&!i!s'.

/I#AMIN 8@• Durasi:

• Dosis :SEH<I )P1 ?< 10M8 $?rifa&ISO BO4 98 55"'

• +(las :,#rido%in( $*it ' 3 (longs to th( class of oth(r ,lain *ita!in

,r(,arations. ;s(d as di(tar# su,,l(!(nts $ki!ia far!a&!i!s'.

/I#AMIN 8 KOMPL(KS• Durasi:

• Dosis : )% s(hari satu tabl(t

• +(las : Bita!in co!,l(%& ,lain 3 ;s(d as di(tar# su,,l(!(nts $ki!ia

far!a&!i!s'.

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 16/21

/I#AMIN "• Durasi:

• Dosis : Adult  100250 !g 12 ti!(s dail# for s(*(ral da#s. S(*(r( cas(s&

1&0002&000 !g dail# could b( ad!inist(r(d• +(las : (longs to th( class of ascorbic acid $*ita!in C'. ;s(d as di(tar#

su,,l(!(nts $sanb(&!i!s'

/I#AMIN K • Durasi:

• Dosis : 100!g ,(r hari

• +(las : !(nadion( 3 (longs to th( class of *ita!in +. ;s(d in th(

tr(at!(nt of h(!orrhag( $ki!ia far!a&!i!s'.

7IN"• Durasi:

• Dosis :

• +(las :

"(I6IM(• Durasi :

• Dosis : Adult & childn wei"hin" ≥0 !" 50100 !g tic( dail#. Se-ere

or intracta$le infections Ma# b( incr(as(d u, to 200 !g tic( dail#.• +(las : c(K%i!( 3 (longs to th( class of thirdg(n(ration c(,halos,orins.

;s(d in th( s#st(!ic tr(at!(nt of inf(ctions. $ki!ia far!a&!i!s'.

"IM(N#IDIN(• Durasi :

• Dosis : Adult  1 tab ) ti!(s dail# 7 2 tab at b(dti!(. >or high(r dos(s& 2

tab ti!(s dail#. *hildn 200 !gkgda# in di*id(d dos(s. ?r(at!(nt

should b( gi*(n for at l(ast k.

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 17/21

• +(las : ci!(tidin( 3 (longs to th( class of H2r(c(,tor antagonists. ;s(d

in th( tr(at!(nt of ,(,tic ulc(r and gastroo(so,hag(al r(u% dis(as(

$8ED' $ar!o%indo far!a&!i!s'.

DIGO6IN• Durasi :

• Dosis : &apid digitali0ation +?2B@ hr,  Adult   tab follo(d at

ad(uat( int(r*al b# 1 tab until co!,(nsation is achi(*(d. *hildn 25

!cgkg& incr(asing at int(r*al until co!,(nsation achi(*(d. Maint(nanc(:

1020 !cgkg dail#. Slo5 digitali0ation +B2< days, 2) tab dail# in

di*id(d dos(s. Maint(nanc(: 1) tab dail#. Inj 0.51 !gda#.Eld(rl# : dos( is bas(d on l(an bod# (ight and nor!al r(nal function for

ag(.H(art failur(: if ,ati(nt is /0 #(ars& lo dos(s&$0.125!g dail# or (*(r#

oth(r da#' should b( us(d. $DI>&20 ?H EDI?IO@& 98 511'.• +(las : (longs to th( class of digitalis gl#cosid(s. ;s(d in th( tr(at!(nt of 

h(art failur( $>ahr(nh(it& !i!s'.

DO6""LIN(• Durasi :

• Dosis : Adult & childn $1 yr  w/ $ !" )ody wt  1st da#: 100 !g tic(

dail# follo(d b# 100 !g dail#. *hildn $1 yr  w/ # !" )ody wt  1st

da#: . !gkg bod# tda# in 2 di*id(d dos(s& th(n 2.2 !gkg bod#

tda#. Se-ere infections 2.2 !gkg bod# t12 hr. Streptococcalinfection Duration of tr(at!(nt !in 10 da#s. Acute gonorrhea 1st da#:

200 !g 7 100 !g at b(dti!(& th(n follo(d b# 100 !g tic( dail# for )

da#s.• +(las : (longs to th( class of t(trac#clin(s. ;s(d in th( s#st(!ic

tr(at!(nt of inf(ctions $ifars&!i!s'.

(&#1&OM"IN• Durasi :

Dosis : Adult & childn $2 !" Ca#'c*e+ tab 1 ca, or 2 ch( tab ti!(sdail#. Ca#let  1 ca,l(t 2 ti!(s dail#.S$r  10 !4 ti!(s dail#. *hildn .2

!" )050 !gkg bod# t dail# in di*id(d dos(s.• +(las : (longs to th( class of !acrolid(s. ;s(d in th( s#st(!ic tr(at!(nt

of inf(ctions.$sanb(& !i!s'.

%&OS(MID(• Durasi :

• Dosis : Tab (de!a  Adult  Initiall# 20"0 !g as a singl( dail# dos(. Dos(

!a# b( car(full# titrat(d u, to 00 !gda# $(%c(,t in ad*anc(d r(nal

failur('. *hildn 12 !gkg bod# t as a singl( dos(. Ma%: 0

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 18/21

!g. Inj Adult  Initiall# 200 !g as a singl( dos( IBIM. Acute pul!onary

ede!a Initiall# 0 !g singl( dos( IB. Ma%: "0 !g. "ere$ral ede!a 20

0 !g ) ti!(s dail# IB. orced diuresis 200 !g in addition to infusion

of (l(ctrol#t( soln. *hildn 1 !gkg bod# t IMIB. Ma%: 20 !g.• +(las : (longs to th( class of highc(iling sulfona!id( diur(tics.$SanoK

<*(ntis&!i!s'.

G(N#AM"IN• Durasi:

• Dosis: <,,l# ) ti!(s dail#

• +(las:(longs to th( class of oth(r to,ical antibiotics us(d in th( tr(at!(nt

of d(r!atological dis(as(s.$sanb(&!i!s'

NS#A#IN• Durasi :

• Dosis : Adult  1 !4. *hildn 12 !4. ?o b( tak(n ti!(s dail#.

• +(las : (longs to th( class of antibiotics. ;s(d in th( tr(at!(nt of

int(stinal inf(ctions $9H<OS&MIMS'

P1(N#OIN• Durasi :

• Dosis :Oral  Adult  Initiall# 100 !g ) ti!(s dail#. *hildn 5 !gkg bod#

tda# in 2 or ) di*id(d dos(s. Ma%: )00 !g dail#. Inj Ma%: 50 !g!inIB. Status epilepticus 1015 !gkg bod# t slo IB $a,,ro% 20 !in in a

/0 kg ,ati(nt'& follo(d b# a !aint(nanc( dos( of 100 !g orall# or IB

(*(r# " hrl#. Neurosurgery100200 !g IM hrl# 7 ,osto,. "ardiac

arrhyth!ia ).55 !gkg bod# t& r(,(at(d onc( if n(c(ssar#. ?otal dail#

dosag(: /001000 !g.• +(las :(longs to th( class of h#dantoin d(ri*ati*(s anti(,il(,tics

$9K(r&!i!s'

/(N#OLIN• Durasi :

• Dosis : Adult & childn Initiall# 2.5 !g& th(n !a# b( incr(as(d to 5 !g.

Ma# b( r(,(at(d ti!(s dail#. Se-ere air5ays o$struction  Adult  ;, to

0 !gda#.• +(las : (longs to th( class of adr(n(rgics for s#st(!ic us(& s(l(cti*( b(ta

2adr(nor(c(,tor agonists. ;s(d in th( tr(at!(nt of obstructi*( aira#

dis(as(s.$8la%oS!ith+lin( Indon(sia&!i!s'

"IM(#IDIN(• Durasi :

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 19/21

• Dosis : Duod(nal ulc(r <dult 12 tab ) ti!(s dail#. Min k. olling(r

Ellison s#ndro!( 7 gastric h#,(racidit# 1 tab ti!(s dail#. Ma%: 2&00 !g

dail#. O(so,hagitis 2 tab ti!(s dail# for " k. Inhibition of gastric acid

s(cr(tion in childn 200 !gkg bod# tda# in di*id(d dos(s.• +(las : (longs to th( class of H2r(c(,tor antagonists. ;s(d in th(

tr(at!(nt of ,(,tic ulc(r and gastroo(so,hag(al r(u% dis(as( $8ED'

$sanb(&!i!s'.

P&OP&ANOLOL• Durasi :

• Dosis : <dult 7 childn 12 #r <ngina ,(ctoris 20 !g ) ti!(s dail#&

incr(as( graduall# to 0 !g ) ti!(s dail#. Ma%: 2002"0 !g dail#.

Cardiac arrh#th!ia 10)0 !g ) ti!(s dail#. H?@ 20 !g ) ti!(s dail#&

incr(asing to 0 !g ) ti!(s dail# aft(r ) da#s. Migrain( $,ro,h#la%is' 0

!g 2) ti!(s dail#. H#,(rtro,hic obstructi*( cardio!#o,ath# 1020 !g ) ti!(s dail#. Childn N12 #r W adult dos(.

• +(las : b(tablock(rs $ >ahr(nh(it&!i!s'

(&&O%S %M(&A#(• Durasi :

• Dosis : lo(r dos(s $1550!g (l(!(ntal ironda#' !a# ha*( si!ilar

(Fcac# and l(ss 8I ad*(rs( (*(nts as co!,ar(d to high(r dos(s $150!g

(l(!(ntal ironda#'

• +(las : iron salt $DI>& 20th (dition ,g /11'

G&IS(O%L/IN• Durasi :

• Dosis :<dult 500 !g dail#. Ma%: 1 g dail#. Childn 10 !gkgda#. (calcitrant

inf(ctions ;, to 12 !th tr(at!(nt.• +(las : 8

PAPA/(&IN• Durasi

• Dosis:

• +(las :

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 20/21

DOSIS DA#A LI7A

AMINOILIN >6> B6>

AN#ASID ?6>

ASAM M((NAMA# ?6> B6><dult Initiall# 500 !g th(n 250 !g hrl#.

8> B6>12% 1tab 50!g

8@ ?6> >x>SEH<I )P1 ?< 10M8

8 "OMP ?6> >6>

"#M ?6> Adult  1 ca,l(t. ?o b( tak(n ) ti!(s dail#

DIA7(PAM >6>Oral 25 !g ) ti!(s dail#

GG ?6> B6>

GLI8(NKLAMID( ?x> Bx>

• Dosis :Initiall# 2.55 !g dail#& should b( ad=ust(d in st(,is( dos( of 2.5!g at about 1 k int(r*al. Ma% dosag(: 10 !gda# $,adonil& !i!s'.

Initiall# 5 !g dail#.• 1.25-20 !g in 1-2 di*id(d dos(s

I8%P&O(N ?6>00 !g ) ti!(s dail#. Analgesia 20000 !g ) ti!(s dail#

1ID&OKLO&#IA7ID +1"#, Bx>

• Durasi: 12 hr.

Dosis :hipertensi : initial& 25 !g O<44V onc( dail#3 !a# incr(as( to 50!g O<44V dail# in singl( or 2 di*id(d dos(s.

KO#&IMOKSA7OL( ?6> B6>

LAK#AS B6> ?6>

LO&A#ADIN ?6>

M(#O&MIN >6>1 tab 2) ti!(s dail# $diafac& !i!s'. 500 mg tab 1 tab ) ti!(s dail#. &50 mg tab 

1 tab tic( dail#. Ma%: ) gda#

7/25/2019 3. Dosis Mims

http://slidepdf.com/reader/full/3-dosis-mims 21/21

NI(DIPIN >6> ?x>510 !g ) ti!(s dail#

P"# ?6> ?o b( tak(n ) ti!(s dail#. Ma% dail# dos(: g

PI&O6I"AM ?x> >x> Bx>&A) OA +arthrosis) generati-e 4oint disease) an'ylosing spondylitis, 

Initiall# 20 !g dail# as a singl( dos(. Acute gout Initiall# 0 !g dail# as a singl(

dos(& follo(d b# 0 !g dail# on th( n(%t da#s in singl( or di*id(d dos(s.

&ANI#IDIN >6> B6>Acti-e $enign gastric ulcer 150 !g 2 ti!(s dail# for " k.

SAL8%#AMOL >6> ?6>Tab Adult  2 !g& S$r  Adult  510 !4. <ll dos(s ar( to b( tak(n ) ti!(s dail#

#(#&ASIKLIN B6>1 ca, ti!(s dail#. 8rucellosis 500 !g ti!(s dail# for ) k.